Search results
Showing results for
A new statement has been released from Professor Peter Horby and Professor Martin Landray, Chief Investigators of the RECOVERY Trial. RECOVERY was established in March as a randomised clinical trial to test a range of potential drugs for COVID-19, including hydroxycholoroquine. The trial has proceeded at unprecedented speed, enrolling over 11,000 patients from 175 NHS hospitals in the UK. The chief investigators have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalised with COVID-19.
Seasonal dynamics and control of malaria: A non-autonomous model incorporating vaccination and drug resistance
Journal article
Onah IS., (2026), Nonlinear Analysis: Real World Applications, 91, 104584 - 104584
Ensuring vaccine cold chain integrity: A rapid and low-cost test for identifying heat-exposed sucrose-containing vaccines
Journal article
Arman BY. et al, (2026), International Journal of Pharmaceutics: X, 11, 100467 - 100467
Perceptions of death, dying and the body in Vietnamese culture: A qualitative exploration from a study examining the potentials of minimally invasive tissue sampling in Vietnam
Journal article
Doan NP. et al, (2026), SSM - Qualitative Research in Health, 9, 100714 - 100714
Modelling seizure-related predictors of epilepsy diagnostic gap in two urban informal settlements of Nairobi using machine learning.
Journal article
Mwanga D. et al, (2026), Global epidemiology, 11
Rickettsial seropositivity in Lao PDR smallholder livestock farms: Implications for animal and human health.
Journal article
Tawfik C. et al, (2026), One health (Amsterdam, Netherlands), 22
The normalisation of under-resourcing limits the potential for improvement of critical care: evidence from a multi-method study of Kenyan hospitals
Journal article
McKnight J. et al, (2026), Social Science & Medicine, 396, 118843 - 118843
Prospects and perils of antimicrobial resistance cluster detection using routinely collected data: an illustration from tertiary hospitals in Thailand representing different data contexts
Journal article
Rangsiwutisak C. et al, (2026), Journal of Hospital Infection, 170, 48 - 59
The epidemiological effect and cost-effectiveness of expanded age eligibility for recombinant zoster vaccination in England
Journal article
Ku C-C. et al, (2026), Vaccine, 78, 128405 - 128405
Validation of the International League Against Epilepsy ( ILAE ) Risk of Bias Tool against the Newcastle–Ottawa Scale in epilepsy research
Journal article
Kwon C. et al, (2026), Epilepsia
Estimating the changing prevalence of molecular markers of artemisinin partial resistance in Plasmodium falciparum malaria in Sub-Saharan Africa
Preprint
Harrison LE. et al, (2026)
Parasitological efficacy of seasonal malaria chemoprevention in Nampula, northern Mozambique
Journal article
Bonnington C. et al, (2026), Transactions of The Royal Society of Tropical Medicine and Hygiene, 120, 258 - 267
Nasopharyngeal Microbiome Composition and its Clinical Correlates in Children Hospitalized with Severe Pneumonia in East Africa.
Journal article
Makori TO. et al, (2026), J Infect Dis
Evidence on mpox clade Ia and clade Ib: A rapid research needs appraisal
Journal article
Spasenoska D. et al, (2026), International Journal of Infectious Diseases, 164, 108348 - 108348
Data reuse in global health: perspectives from actors in policy, funding and research
Journal article
Waithira N. et al, (2026), BMJ Global Health, 11, e021974 - e021974
Impact of an electronic clinical decision support algorithm (eCDSA) on antibiotic prescribing in primary care in Cambodia: A cluster randomised controlled trial
Journal article
Wynberg E. et al, (2026), International Journal of Infectious Diseases, 164, 108382 - 108382
Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Journal article
Jo H. et al, (2026), The Lancet Respiratory Medicine, 14, 233 - 255
Urinary carbonic anhydrase 1 excretion is a marker of hemolysis-triggering conditions suitable for point-of-care testing
Journal article
Hulikova A. et al, (2026), Blood Global Hematology, 2, 100058 - 100058
ssessment of antibody responses to Anopheles SG6-P1 and Aedes N-term 34 kDa salivary peptides: a randomised human-challenge trial of controlled exposures to vector bites.
Journal article
Chaumeau V. et al, (2026), BMC medicine
pplying WHO Prioritization Criteria for Moderate Wasting: Programmatic Implications.
Journal article
Potani I. et al, (2026), Maternal & child nutrition, 22